48 PRIMECAP Management Biomarin Pharmaceutical - Registered Shares Trades
PRIMECAP Management's position in Biomarin Pharmaceutical - Registered Shares is currently worth $1.09 Billion. That's 0.84% of their equity portfolio (32nd largest holding). The investor owns 9.15% of the outstanding Biomarin Pharmaceutical - Registered Shares stock. The first Biomarin Pharmaceutical - Registered Shares trade was made in Q1 2013. Since then PRIMECAP Management bought shares 25 more times and sold shares on 22 occasions. The investor's estimated purchase price is $1.36 Billion, resulting in a loss of 20%.
News about Biomarin Pharmaceutical Inc. - Registered Shares and PRIMECAP Management
PRIMECAP Management Bolsters Stake in Biomarin Pharmaceutical Inc
PRIMECAP Management Bolsters Stake in Biomarin Pharmaceutical Inc
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Position Boosted by Panagora Asset Management Inc.
… by institutional investors. BioMarin Pharmaceutical Price Performance BMRN opened at … Sanford C. Bernstein upgraded BioMarin Pharmaceutical from an “under...
BioMarin may be more of an M&A target with activist Elliott pact - analysts
Biomarin (BMRN) stock rose after activist Elliott Management enteraed a cooepratoon pact and a strategic review committee was established
BioMarin establishes strategic review committee, expands board
BioMarin (BMRN) said it has established a strategic review committee, temporarily expanded its board and entered into a cooperation agreement with Elliott In...